share_log

藥明康德:海外監管公告

WUXI APPTEC: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

Hong Kong Stock Exchange ·  Apr 29 21:20
Summary by Futu AI
药明康德於2024年4月29日召開董事會,審議通過變更公司註冊資本及修改公司章程的議案。此次變更是根據股東大會授權,並涉及多項股份變動,包括债转股申请、限制性股票與股票期权激励计划的行权、股份回购注销等。股份變動後,公司註冊資本由2,962,088,310元降至2,933,336,997元,總股本由2,962,088,310股變更為2,933,336,997股。公司章程相關條款亦將進行修訂以反映上述變更。
药明康德於2024年4月29日召開董事會,審議通過變更公司註冊資本及修改公司章程的議案。此次變更是根據股東大會授權,並涉及多項股份變動,包括债转股申请、限制性股票與股票期权激励计划的行权、股份回购注销等。股份變動後,公司註冊資本由2,962,088,310元降至2,933,336,997元,總股本由2,962,088,310股變更為2,933,336,997股。公司章程相關條款亦將進行修訂以反映上述變更。
Ming Kand Pharmaceuticals convened its Board of Directors on 29 April 2024 to consider a motion to amend the registered capital of the Company and amend the Articles of Association. This change is authorized by the General Meeting and involves a number of share changes, including bond transfer requests, enforcement of the Restricted Stock and Stock Futures Incentive Program, share buyback and marketing, and more. After the change in shares, the registered capital of the company decreased from $2,962,088,310 to $2,933,336,997 and the total share capital changed from 2,962,088,310 shares to 2,933,336,997 shares. The relevant terms of the Articles of Association will also be amended to reflect the above changes.
Ming Kand Pharmaceuticals convened its Board of Directors on 29 April 2024 to consider a motion to amend the registered capital of the Company and amend the Articles of Association. This change is authorized by the General Meeting and involves a number of share changes, including bond transfer requests, enforcement of the Restricted Stock and Stock Futures Incentive Program, share buyback and marketing, and more. After the change in shares, the registered capital of the company decreased from $2,962,088,310 to $2,933,336,997 and the total share capital changed from 2,962,088,310 shares to 2,933,336,997 shares. The relevant terms of the Articles of Association will also be amended to reflect the above changes.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.